procysbi

Horizon's NDA for Procysbi New Dosage Form Accepted by FDA
Yahoo/Zacks.com
Sun, 07/21/19 - 04:21 pm
Horizon Therapeutics
procysbi
nephropathic cystinosis
Four New Patents Issued, PROCYSBI® Granted Additional U.S. Orphan Exclusivity
Yahoo
Mon, 01/25/16 - 10:00 am
procysbi
patents
Raptor Pharmaceutical
orphan drugs
Big Downside Ahead for Raptor?
24/7 Wall St
Tue, 07/7/15 - 11:34 am
Raptor Pharmaceuticals
procysbi
Raptor's Procysbi approved for rare disease in EU
PharmaTimes
Sat, 09/14/13 - 11:05 am
Raptor Pharmaceuticals
procysbi
nephropathic cystinosis
Will You Adopt This Orphan Drug?
Motley Fool
Sat, 09/7/13 - 12:00 pm
nephropathic cystinosis
Raptor Pharmaceuticals
procysbi
Raptor receives positive orphan drug opinion from EU committee
Yahoo/Fly on the Wall
Mon, 07/22/13 - 10:19 am
Raptor Pharmaceuticals
Europe
procysbi
US Exclusivity for Raptor's Procysbi
Yahoo/Zacks
Wed, 06/26/13 - 10:37 am
Raptor Pharmaceuticals
procysbi
nephropathic cystinosis
orphan drugs
Raptor Pharma's Procysbi Launched in the US
Yahoo/Zacks
Sat, 06/22/13 - 10:14 am
Raptor Pharmaceuticals
procysbi
nephropathic cystinosis
US FDA approves Raptor Pharma's Procysbi for treatment of nephropathic cystinosis
Pharmabiz
Sun, 05/5/13 - 11:07 am
Raptor Pharmaceuticals
procysbi
nephropathic cystinosis
Raptor's FDA Approval Is New Test For Orphan Drug Pricing
TheStreet.com
Wed, 05/1/13 - 09:09 am
FDA
Raptor Pharmaceuticals
orphan drugs
procysbi
nephropathic cystinosis
2 Orphan Drugmakers With Upcoming Catalysts
Seeking Alpha
Wed, 04/24/13 - 04:46 pm
orphan drugs
Raptor Pharmaceuticals
Aegerion
Juxtapid
procysbi
Procysbi (Raptor Pharmaceuticals): A Long Acting Cysteine For The Treatment Of Cystinosis
Seeking Alpha
Wed, 03/27/13 - 09:56 am
Raptor Pharmaceuticals
procysbi
cystinosis
Raptor To Rise On Proven Strategy & Upcoming FDA Decision
Seeking Alpha
Sat, 12/29/12 - 10:31 am
Raptor
procysbi
nephropathic cystinosis
Raptor Drug FDA Action Date Delayed
Yahoo/Zacks
Fri, 12/28/12 - 11:26 am
FDA
Raptor Pharmaceuticals
procysbi
nephropathic cystinosis
Raptor Pharma Says FDA Extends PROCYSBI NDA Review By 3 Months
NASDAQ
Sat, 12/22/12 - 01:00 pm
procysbi
Raptor Pharmaceuticals
nephropathic cystinosis